Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma. Melting Point: 172-175C (dec.) Solubility: DMSO, Methanol
Molekulargewicht:
1096.326005
Formulierung:
Supplied as a White Solid
CAS Nummer:
[127984-74-1]
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten